1 While many people are aware of the unpleasant consequences of this condition, few know that it can be caused by a variety of underlying medications, including using a GLP-1 (glucagon-like peptide-1) agonist drug like Ozempic
In the first countries, the US, Denmark and Norway, all the launches had very, very steep uptakes, Jorgensen said
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling
Semaglutide Not Associated with Increased Risk of Eye Disorders, 19 August 2025, The use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION), 27 June 2025, WHO, PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy, 06 June 2025, European Medicine Agency, Kai-Yang Chen, Hoi-Chun Chan, Chi-Ming Chan, does semaglutide increase the risk of non-arteritic anterior ischemic optic neuropathy